BioLargo Balance Sheet - Annual (OTCMKTS:BLGO)

Add to My Stocks
$0.31 $0.02 (6.06%) BLGO stock closing price Jul 16, 2018 (Closing)

The financial analysis of a company involves interpreting the income statement, balance sheet and cash flow statements of the company to draw insights like we've done in our BioLargo stock analysis. Financial strength can be guaged by performing BioLargo stock analysis and by analyzing the balance sheet. Annual results are typically accompanied with the company releasing financial statements. BioLargo balance sheet indicates an asset turnover ratio of 0.71 and debt to equity ratio of -. Also check BioLargo revenue and BioLargo operating cash flow for the same period.

View latest 10 year balance sheet data to check BioLargo financial performance.
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Jan - Dec2017201620152014201320122011201020092008
Cash-1.91M1.76M-------
Marketable Securities----------
Receivables----------
Inventory----------
Raw Materials----------
Work In Progress----------
Finished Goods----------
Notes Receivable----------
Other Current Assets----------
Total Current Assets
1.15M2.01M1.89M-------
Property Plant & Equipment----------
Accumulated Depreciation----------
Net Property Plant & Equipment
----------
Investment & Advances----------
Other Non-Current Assets----------
Deferred Charges----------
Intangibles---------9.63M
Deposits & Other Assets----------
Total Assets
1.49M2.11M1.91M------10M
Notes Payable3.99M------1.54M1.51M-
Accounts Payable--------1.27M-
Current Portion Long-Term Debt----------
Current Portion Capital Leases----------
Accrued Expenses----------
Income Taxes Payable----------
Other Current Liabilities----------
Total Current Liabilities
4.21M1.15M----1.37M2.38M3.46M2.08M
Mortgages----------
Deferred Taxes/Income----------
Convertible Debt-1.72M--------
Long-Term Debt----------
Non-Current Capital Leases----------
Other Long-Term Liabilities----------
Total Liabilities
4.9M2.88M----1.76M3.05M4.04M2.65M
Minority Interest----------
Preferred Stock----------
Common Stock Net----------
Capital Surplus97.09M90.6M84.41M78.51M74.84M72.46M65.9M60.88M53.87M49.48M
Retained Earnings-101.2M-91.91M-84.07M-79.01M-75.32M-72.79M-67.46M-63.51M-57.76M-42.15M
Treasury Stock----------
Other Liabilities-----0.13M-----
Shareholders Equity-3.4M-0.77M1.14M-0.39M-0.56M-0.28M-1.51M-2.59M-3.86M7.35M
Total Liabilities & Shareholders Equity1.49M2.11M1.91M------10M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Apart from balance sheet items, an investor would do well to keep track of the BioLargo stock price by looking at BioLargo historical stock prices. One can compare PE with industry average by looking at the BioLargo PE ratio chart. The common balance sheet items are:

  • Assets: BLGO total assets, which was at $1.49M for 2017 is a balance sheet item representing value of what BioLargo owns. Assets are brought to aid a firms operations, or to increase its economic value. It must be noted that tech stocks may not have a lot of assets, as the value for these companies is often derived from future earning potential.
  • Liabilities or obligations comprise of current liabilities that include short term loans, amounts payable to suppliers, or any other outstanding payments including long term liabilities that take into account long term loans for funding large projects. The total liabilities for BioLargo is $4.9M. Shareholders' equity comes under liabilities as it is money the company owes the holders of BLGO stock.

BioLargo Balance Sheet - Key Ratios

Current ratio
0.22
Debt to equity ratio
0
Asset turnover ratio
0.71
Receivables turnover
8.49